Provided by Tiger Fintech (Singapore) Pte. Ltd.

CARDIO DIAGNOSTICS HOLDINGS INC

0.4243
+0.02235.55%
Post-market: 0.4114-0.0129-3.04%19:55 EDT
Volume:573.29K
Turnover:239.71K
Market Cap:22.13M
PE:-1.12
High:0.4438
Open:0.4011
Low:0.4004
Close:0.4020
Loading ...

Company Profile

Company Name:
CARDIO DIAGNOSTICS HOLDINGS INC
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
8
Office Location:
311 West Superior Street,Suite 444,Chicago,Illinois,United States
Zip Code:
60654
Fax:
- -
Introduction:
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Directors

Name
Position
Meeshanthini V. Dogan
Chief Executive Officer and Director
Warren Hosseinion
Non-Executive Chairman and Consultant
Robert Philibert
Chief Medical Officer and Director
James Intrater
Director
Paul F. Burton
Director

Shareholders

Name
Position
Meeshanthini V. Dogan
Chief Executive Officer and Director
Elisa Luqman
Chief Financial Officer
Robert Philibert
Chief Medical Officer and Director
Timur Dogan
Chief Technology Officer